Klampenborg, Denmark

Søren Peter Olesen


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Søren Peter Olesen: Contributions to Potassium Channel Research

Introduction

Søren Peter Olesen, a prominent inventor based in Klampenborg, Denmark, has made significant contributions to the field of pharmacology through his innovative research and development. With a total of three patents to his name, Olesen is recognized for his pioneering work on potassium channel blocking agents, particularly focusing on bis(benzimidazole) derivatives.

Latest Patents

Olesen's latest patents include groundbreaking inventions such as "Bis(benzimidazole) derivatives serving as potassium blocking agents" and "Potassium channel blocking agents." These inventions demonstrate his commitment to advancing the understanding and treatment of various medical conditions linked to potassium channels.

Career Highlights

Currently working at Neurosearch A/S, Olesen has played a vital role in the company’s mission to innovate and improve therapeutic solutions. His focus on potassium channel research has positioned him as a key figure in the development of novel drug candidates aimed at addressing neurological disorders.

Collaborations

Throughout his career, Olesen has collaborated with notable professionals in the field, including his coworkers Bo Skaaning Jensen and Lene Teuber. These partnerships have enriched his research and contributed to the successful outcomes of his patented inventions.

Conclusion

Søren Peter Olesen's contributions to the field of pharmacology through his patents and research continue to pave the way for advancements in medical therapies. His dedication to innovation and collaboration highlights the essential role inventors play in transforming scientific ideas into practical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…